株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の血液ガスおよび電解質分析装置市場:成長、動向、および予測(2020年~2025年)

Blood Gas and Electrolyte Analyzer Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 921919
出版日 ページ情報 英文 111 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.80円で換算しております。
Back to Top
世界の血液ガスおよび電解質分析装置市場:成長、動向、および予測(2020年~2025年) Blood Gas and Electrolyte Analyzer Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年01月01日 ページ情報: 英文 111 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

世界の血液ガス・電解質分析装置市場は、集中治療室の患者数の増加や、医療施設との政府および民間部門の協力などにより需要が促進されています。また、ポータブルの血液ガス・電解質分析装置は、取扱いの容易さ、メンテナンス要件の少なさのため採用率が向上しており、企業による製品の開発とマーケティングへの投資などの要因と相まって急速な成長が見込まれています。ただし、分析装置のコスト、償還の問題、複雑な規制などは同市場の成長を妨げるおそれがあります。

当レポートは世界の血液ガス・電解質分析装置市場について調査しており、市場機会や動向、成長および阻害要因、モダリティ・製品・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
    • 病院の救急ユニットの患者数増加
    • 血液ガス・電解質分析装置の技術的進歩
    • 医療施設の改善における政府および民間部門の参加の増加
  • 市場阻害要因
    • 分析装置の高いコスト
    • 規制と償還に関する問題
  • ポーターのファイブフォース分析

第5章 市場セグメンテーション

  • モダリティ別
    • ベンチトップ
    • ポータブル
  • 製品別
    • 血液ガス分析装置
    • 電解質分析装置
    • 複合分析装置
    • その他
  • エンドユーザー別
    • 中央研究所
    • ポイントオブケア
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Abbott Laboratories
    • Dalko Diagnostics
    • Erba Diagnostics
    • F Hoffman La Roche Ltd
    • Medica Corporation
    • Nova Biomedical
    • Seimens Healthineers
    • Werfen
    • Danaher Corporation

第7章 市場機会および今後の動向

目次
Product Code: 67611

Market Overview

The analyzers are important in the critical care units to determine the blood gas, pH, electrolytes, and some metabolites in the whole blood specimen. The technological advancement in the past decade has significantly improved the method of diagnosis and treatment in the healthcare facilities. The recent advances have enabled clinicians to direct therapy and improve patient outcomes. A large number of basic and complicated parameters are now being carried out for patients suffering from life-threatening respiratory disturbances and acid-base imbalances. For example, the epic Blood Analysis System wireless solution for testing by Alere, Inc (Abbott Laboratories) which features smartcard technology offers 11 tests from a very small sample of blood (92 µL, about 1/10th of a CC, sample). Other factors such as the growing patient population in the critical care units and government and private sectors collaboration with healthcare facilities, all drive the demand of the blood gas electrolyte analyzer. Some of the major restraining factors in the market include the cost of the analyzer, reimbursement issues, and complicated regulations.

Scope of the Report

The blood gas and electrolyte analyzers are useful medical devices for the detection of metabolic imbalances, and measurement of renal and cardiac functions. It is traditionally performed in the clinical chemistry laboratory, but, now becoming popular and common in the point-of-care testing. The scope of this market report is segmented by modality, product, and end-user, among different geographies.

Key Market Trends

Portable Blood Gas and Electrolyte Analyzers is Expected to Grow at Better Rate than Other, Over the Forecast Period

The portable devices are easy to use, handle and with minimum maintenance requirement which helps in its better adoption rate. There are several companies that are investing in the development and marketing of these products. Though there is the edge for the portable devices over the conventional devices, the concerns and challenges arise when there are being operated by the non-laboratory staff such as nurses and physicians, which sometimes restricts the extent of results being obtained. With that, in the emergency and critical care settings, it is important for the doctors/physicians and laboratorians to build upon the synergistic efforts towards using portable devices in POCT and conventional laboratory settings. With that, the positives and benefits of using such devices are more, which drives the adoption rate of these products in the market, over the forecast period.

North America is Expected to Dominate the Market Among Other Regions, over the Forecast Period

North America is expected to dominate this market in terms of revenue generation, over the forecast period. The large presence of domestic and international medical devices companies from both the developed and emerging markets boost the demand and growth of analyzes in the country. The better network between the multispecialty hospitals with the insurance companies and medical device companies drives the importance of this market in the United States. Medical tourism also attracts many patients from many countries to get better healthcare facilities in the region. The growing preference towards the point of care testing by both the companies and hospitals fuel the growth of the studied market in the region. Europe is expected to follow next by market size because of the significant presence of medical device companies and the old age population across the region.

Competitive Landscape

The companies in this market have advanced in providing analyzer with display monitors to monitor the patients before electronically transferring them for permanent record within information management systems. Some of the major players active in this market include Abbott laboratories, F Hoffman La Roche Ltd, Siemens Healthineers, Medica Corporation, Danaher Corporation, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Number of Patients in Emergency Units of Hospitals
    • 4.2.2 Technological Advacements in Blood Gas and Electrolyte Analyzers
    • 4.2.3 Increasing Government and Private Sector Participation in Improving Healthcare Facilities
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Analyzers
    • 4.3.2 Issues Regarding Regulation and Reimbursement
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Modality
    • 5.1.1 Benchtop
    • 5.1.2 Portable
  • 5.2 By Product
    • 5.2.1 Blood Gas Analyzer
    • 5.2.2 Eelctrolyte Analyzer
    • 5.2.3 Combined Analyzer
    • 5.2.4 Other products
  • 5.3 By End User
    • 5.3.1 Centralized Laboratories
    • 5.3.2 Point of Care
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 France
      • 5.4.2.2 Germany
      • 5.4.2.3 United Kingdom
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Dalko Diagnostics
    • 6.1.3 Erba Diagnostics
    • 6.1.4 F Hoffman La Roche Ltd
    • 6.1.5 Medica Corporation
    • 6.1.6 Nova Biomedical
    • 6.1.7 Seimens Healthineers
    • 6.1.8 Werfen
    • 6.1.9 Danaher Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top